The Louisa Carman Medical Debt Relief Act (P.L. 2024, c. 48), which became fully effective in the summer of 2025, establishes one of the most stringent and consumer-friendly medical debt protection frameworks in the United States. Designed explicitly to insulate patients from the catastrophic financial fallout of involuntary medical expenses, the Act imposes severe restrictions on the timeline, mechanics, and financial yield of medical debt collection. The statute meticulously defines “medical debt” to include obligations arising from health care services and necessary medical items, while explicitly excluding elective cosmetic procedures, veterinary care, and general credit card debt not specifically dedicated to health services.

The legislative framework operates primarily by imposing mandatory delays and structural settlement requirements before any litigation can commence. First, the legislation mandates a strict 120-day “cooling-off” period. Medical creditors and third-party debt collectors are legally prohibited from initiating any collection action—including reporting to credit bureaus, filing lawsuits, placing property liens, or executing wage garnishments—until 120 days have elapsed since the first billing statement was transmitted. Furthermore, a creditor must provide at least one additional billing statement and a formalized 30-day notice explicitly detailing the specific collection actions intended to be taken before those actions can be executed.

Prior to initiating any formal litigation or enforcement action, the creditor is statutorily obligated to offer the patient a “reasonable payment plan”. The statutory definition of a reasonable payment plan heavily favors the debtor: the plan cannot demand monthly payments exceeding 3% of the patient’s known monthly income, must offer a repayment duration ranging from six months to five years, and must explicitly incorporate a 60-day grace period for late payments. If a patient accepts and complies with this plan, all external collection actions must be immediately suspended. Furthermore, if a creditor or debt collector is aware that an internal or external review of a health insurance coverage decision is pending, all collection communications and litigation efforts must cease entirely.